Article Text

Download PDFPDF
Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies
  1. S Sangle,
  2. D P D’Cruz,
  3. G R V Hughes
  1. Lupus Research Unit, The Rayne Institute, Lambeth Wing, St Thomas’ Hospital, London SE1 7EH, UK
  1. Correspondence to:
    Dr S Sangle
    shirish.sanglegstt.sthames.nhs.uk

Abstract

Background: Livedo may be an independent risk factor for pregnancy morbidity, additional to the known risks associated with the presence of antiphospholipid antibodies (aPL).

Objective: To determine the prevalence of pregnancy related morbidity in patients with widespread livedo reticularis who are persistently negative for aPL.

Patients and methods: 52 patients with widespread livedo reticularis were studied: 31 fulfilled ACR criteria for SLE, 21 had a lupus-like illness; all were negative for aPL. All patients had livedo (racemosa or reticularis type) on their extremities, trunk, and/or buttocks.

Result: 33 (63%) patients had pregnancy related morbidity. 22 patients had up to 9 miscarriages, 15 patients had >3 miscarriages, 2 had 2 miscarriages, 4 had a fetal death (>10 weeks), 17 had pre-eclampsia, and 4 patients had premature delivery. 19 patients had no pregnancy related morbidity. Overall morbidity was similar in the patients with lupus and lupus-like disease.

Conclusion: Pregnancy related morbidity in lupus is known to be associated with the presence of aPL. This study suggests that pregnancy loss may also be independently associated with widespread livedo reticularis in patients who are aPL negative. A larger study is needed.

  • aPL, antiphospholipid antibodies
  • APS, antiphospholipid syndrome
  • SLE, systemic lupus erythematosus
  • antiphospholipid syndrome
  • antiphospholipid antibodies
  • livedo reticularis
  • pregnancy morbidity

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes